Answer Details

Here are West Coast cancer centers that are consistently top-rated nationally and are NCI-designated Comprehensive Cancer Centers (a strong quality signal), grouped by state: California City of Hope (Duarte/Los Angeles area) — Ranked top-5 nationally for cancer care in U.S. News 2024–25; large clinical trials portfolio and transplant expertise. Oncology News Central +1 UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco) — NCI Comprehensive; UCSF is regularly among the best hospitals in CA and nationally, with strong oncology programs and new UCSF-Stanford collaboration hub. Cancer.gov +2 UCSF Health +2 Stanford Cancer Institute (Palo Alto) — NCI Comprehensive; broad specialty depth and major research footprint. Cancer.gov UCLA Jonsson Comprehensive Cancer Center (Los Angeles) — NCI Comprehensive; nationally ranked for cancer. Cancer.gov UC San Diego Moores Cancer Center (La Jolla/San Diego) — NCI Comprehensive; region’s academic leader with strong trials access. Cancer.gov Cedars-Sinai (Los Angeles) — Highly rated for cancer care in Newsweek’s national rankings. rankings.newsweek.com Washington Fred Hutchinson Cancer Center / UW Medicine (Seattle) — NCI Comprehensive; internationally recognized for bone marrow transplant, immunotherapy, and trials. Cancer.gov Oregon OHSU Knight Cancer Institute (Portland) — NCI Comprehensive; precision oncology and early-detection leadership. Cancer.gov How to choose among them Match to your cancer type. Outcomes and expertise vary by disease; look for centers leading trials or programs specifically for your diagnosis. The NCI directory is a good starting point to find programs by location. Cancer.gov Clinical trials access. Academic/NCI centers typically offer the most trials, which can open newer options. Cancer.gov Practical fit. Verify insurance, travel logistics, and multidisciplinary clinics for your specific cancer. If you share your diagnosis (and whether you’re looking for adult or pediatric care), I can shortlist the best West Coast program(s) for that disease and point to active trials.